Cargando…
S110: ACUTE AND CHRONIC PAIN MANAGEMENT IN SICKLE CELL DISEASE: OUTCOMES OF AN ENGLISH NATIONAL AUDIT.
Autores principales: | Lugthart, S, Kotsiopoulou, S, Luqmani, A, Eleftheriou, P, Drasar, E, Brown, R, Webster, A, Chakravorty, S, Stuart-Smith, S, Velangi, M, Atoyebi, W, Howard, J, Telfer, P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812122/ http://dx.doi.org/10.1097/01.HS9.0000821408.35780.c7 |
Ejemplares similares
-
5609968 REAL-WORLD PATIENT-REPORTED OUTCOMES AND WEARABLE METRIC CORRELATIONS: REMOTE DAILY MONITORING FOR EXPLORATION OF QUALITY OF LIFE IN SICKLE CELL DISEASE
por: Agrippa, O.A., et al.
Publicado: (2023) -
5612984 AUDIT OF TRUST COMPLIANCE WITH BSH GUIDELINES FOR UTILISATION OF HYDROXYCARBAMIDE IN PATIENTS WITH SICKLE CELL DISEASE
por: Barker, R., et al.
Publicado: (2023) -
Real-time national survey of COVID-19 in hemoglobinopathy and rare inherited anemia patients
por: Telfer, Paul, et al.
Publicado: (2020) -
5610107 LIVE OUTCOMES AND BIOMETRIC MONITORING: POTENTIAL IMPLICATIONS FOR PATIENT QUALITY OF LIFE IN SICKLE CELL DISEASE
por: Agrippa, O.A., et al.
Publicado: (2023) -
S118: LONG-TERM SAFETY AND EFFICACY OF VOXELOTOR FOR PATIENTS WITH SICKLE CELL DISEASE: RESULTS FROM AN OPEN-LABEL EXTENSION OF THE PHASE 3 HOPE TRIAL
por: Achebe, M, et al.
Publicado: (2022)